Cargando…

Altered monocyte activation markers in Tourette’s syndrome: a case–control study

BACKGROUND: Infections and immunological processes are likely to be involved in the pathogenesis of Tourette’s syndrome (TS). To determine possible common underlying immunological mechanisms, we focused on innate immunity and studied markers of inflammation, monocytes, and monocyte-derived cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales: Matz, Judith, Krause, Daniela L, Dehning, Sandra, Riedel, Michael, Gruber, Rudolf, Schwarz, Markus J, Müller, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356225/
https://www.ncbi.nlm.nih.gov/pubmed/22471395
http://dx.doi.org/10.1186/1471-244X-12-29
_version_ 1782233524672135168
author Matz, Judith
Krause, Daniela L
Dehning, Sandra
Riedel, Michael
Gruber, Rudolf
Schwarz, Markus J
Müller, Norbert
author_facet Matz, Judith
Krause, Daniela L
Dehning, Sandra
Riedel, Michael
Gruber, Rudolf
Schwarz, Markus J
Müller, Norbert
author_sort Matz, Judith
collection PubMed
description BACKGROUND: Infections and immunological processes are likely to be involved in the pathogenesis of Tourette’s syndrome (TS). To determine possible common underlying immunological mechanisms, we focused on innate immunity and studied markers of inflammation, monocytes, and monocyte-derived cytokines. METHODS: In a cross-sectional study, we used current methods to determine the number of monocytes and levels of C-reactive protein (CRP) in 46 children, adolescents, and adult patients suffering from TS and in 43 healthy controls matched for age and sex. Tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), soluble CD14 (sCD14), IL1-receptor antagonist (IL1-ra), and serum neopterin were detected by immunoassays. RESULTS: We found that CRP and neopterin levels and the number of monocytes were significantly higher in TS patients than in healthy controls. Serum concentrations of TNF-alpha, sIL1-ra, and sCD14 were significantly lower in TS patients. All measured values were within normal ranges and often close to detection limits. CONCLUSIONS: The present results point to a monocyte dysregulation in TS. This possible dysbalance in innate immunity could predispose to infections or autoimmune reactions.
format Online
Article
Text
id pubmed-3356225
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33562252012-05-19 Altered monocyte activation markers in Tourette’s syndrome: a case–control study Matz, Judith Krause, Daniela L Dehning, Sandra Riedel, Michael Gruber, Rudolf Schwarz, Markus J Müller, Norbert BMC Psychiatry Research Article BACKGROUND: Infections and immunological processes are likely to be involved in the pathogenesis of Tourette’s syndrome (TS). To determine possible common underlying immunological mechanisms, we focused on innate immunity and studied markers of inflammation, monocytes, and monocyte-derived cytokines. METHODS: In a cross-sectional study, we used current methods to determine the number of monocytes and levels of C-reactive protein (CRP) in 46 children, adolescents, and adult patients suffering from TS and in 43 healthy controls matched for age and sex. Tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), soluble CD14 (sCD14), IL1-receptor antagonist (IL1-ra), and serum neopterin were detected by immunoassays. RESULTS: We found that CRP and neopterin levels and the number of monocytes were significantly higher in TS patients than in healthy controls. Serum concentrations of TNF-alpha, sIL1-ra, and sCD14 were significantly lower in TS patients. All measured values were within normal ranges and often close to detection limits. CONCLUSIONS: The present results point to a monocyte dysregulation in TS. This possible dysbalance in innate immunity could predispose to infections or autoimmune reactions. BioMed Central 2012-05-18 /pmc/articles/PMC3356225/ /pubmed/22471395 http://dx.doi.org/10.1186/1471-244X-12-29 Text en Copyright ©2012 Matz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Matz, Judith
Krause, Daniela L
Dehning, Sandra
Riedel, Michael
Gruber, Rudolf
Schwarz, Markus J
Müller, Norbert
Altered monocyte activation markers in Tourette’s syndrome: a case–control study
title Altered monocyte activation markers in Tourette’s syndrome: a case–control study
title_full Altered monocyte activation markers in Tourette’s syndrome: a case–control study
title_fullStr Altered monocyte activation markers in Tourette’s syndrome: a case–control study
title_full_unstemmed Altered monocyte activation markers in Tourette’s syndrome: a case–control study
title_short Altered monocyte activation markers in Tourette’s syndrome: a case–control study
title_sort altered monocyte activation markers in tourette’s syndrome: a case–control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356225/
https://www.ncbi.nlm.nih.gov/pubmed/22471395
http://dx.doi.org/10.1186/1471-244X-12-29
work_keys_str_mv AT matzjudith alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy
AT krausedanielal alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy
AT dehningsandra alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy
AT riedelmichael alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy
AT gruberrudolf alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy
AT schwarzmarkusj alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy
AT mullernorbert alteredmonocyteactivationmarkersintourettessyndromeacasecontrolstudy